Prognostic value of pretreatment PET/CT lean body mass-corrected parameters in patients with hepatocellular carcinoma
Conclusion
Pretreatment 18F-FDG-PET/CT lean body mass-corrected parameters can predict the OS in patients with HCC. Moreover, lbmSUVmax and AST, as the independent predictors of OS, could supplement the prognostic value of the BCLC staging system.
Source: Nuclear Medicine Communications - Category: Nuclear Medicine Tags: Original Articles Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | CT Scan | Hepatocellular Carcinoma | Liver | Liver Cancer | Nuclear Medicine | Statistics | Study | Urology & Nephrology